Payer PolicyActive
SURG.00128 Implantable Left Atrial Hemodynamic Monitor
ANTHEM-SURG.00128
Anthem
Effective: October 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses implantable left atrial hemodynamic monitoring devices used in heart failure management, such as the HeartPOD System, Promote LAP System, and V-LAP System. Anthem considers these devices investigational and not medically necessary; therefore, they are not covered for any indication. There are no covered indications or exceptions—use of these implantable monitors is excluded from coverage in all scenarios.
Coverage Criteria Preview
Key requirements from the full policy
"Left atrial hemodynamic monitoring utilizing implantable device (for example, HeartPOD⢠System, Promote®LAP System, and V-LAP⢠System) is consideredinvestigational and not medically necessaryf..."
Sign up to see full coverage criteria, indications, and limitations.